B10 Other human herpesviruses

Name of the Condition

• Other human herpesviruses

Summary

Other human herpesviruses represent a group of viral infections caused by herpesviruses other than herpes simplex virus (HSV), varicella-zoster virus (VZV), or Epstein-Barr virus (EBV). These infections can affect various organ systems and may present with diverse clinical manifestations, ranging from mild, self-limiting illnesses to severe, systemic disease. The condition encompasses infections caused by viruses such as cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8), each with distinct clinical profiles.

Causes

Other human herpesviruses are caused by distinct members of the Herpesviridae family, including cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). Transmission occurs through direct contact with infected bodily fluids, respiratory droplets, or vertical transmission (e.g., from mother to fetus). These viruses establish lifelong latency in host cells after primary infection and may reactivate under certain conditions.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Advanced age, particularly for HHV-8-associated conditions like Kaposi sarcoma.
• Congenital or perinatal exposure to cytomegalovirus.
• Close contact with individuals shedding virus, especially in healthcare or childcare settings.
• Underlying hematologic or lymphoid malignancies.

Symptoms

• Fever, fatigue, and malaise (common across many herpesvirus infections).
• Organ-specific manifestations, such as hepatitis (CMV), pneumonitis (CMV), or encephalitis (HHV-6).
• Rash or mucocutaneous lesions (e.g., Kaposi sarcoma in HHV-8 infection).
• Gastrointestinal symptoms, including diarrhea or abdominal pain (CMV colitis).
• Neurologic symptoms, such as seizures or cognitive changes (HHV-6 encephalitis).

Diagnosis

Diagnosis is based on clinical presentation, laboratory testing, and imaging. Serologic tests detect antibodies to specific herpesviruses, while PCR assays identify viral DNA in blood, tissue, or bodily fluids. Viral culture or antigen detection may be used in select cases. Imaging (e.g., CT, MRI) evaluates organ involvement, such as pneumonitis or encephalitis. Biopsy of affected tissue confirms histopathologic changes, such as inclusion bodies or atypical cells.

Treatment Options

Treatment depends on the specific virus, severity, and patient factors. Antiviral medications (e.g., ganciclovir, foscarnet) are used for cytomegalovirus or HHV-6 infections in immunocompromised patients. Supportive care, including hydration and symptom management, is standard for mild cases. For HHV-8-associated malignancies, chemotherapy or targeted therapy may be required. Prophylactic antivirals are sometimes used in high-risk populations (e.g., transplant recipients).

Prognosis and Follow-Up

Prognosis varies by virus and host immunity. Immunocompetent individuals with mild infections typically recover fully. Severe or disseminated disease, especially in immunocompromised patients, may have higher morbidity and mortality. Follow-up includes monitoring for recurrence, organ function (e.g., liver, kidney), and immune status. Long-term surveillance is recommended for HHV-8-associated conditions like Kaposi sarcoma.

Complications

• Organ damage, such as liver failure (CMV hepatitis) or respiratory failure (CMV pneumonitis).
• Neurologic sequelae, including encephalitis or cognitive impairment (HHV-6).
• Malignancies, such as Kaposi sarcoma (HHV-8) or lymphomas.
• Transplant rejection or graft dysfunction in immunosuppressed patients.
• Congenital abnormalities in infants with perinatal cytomegalovirus infection.

Lifestyle & Prevention

• Practice good hygiene, including handwashing, to reduce transmission.
• Avoid close contact with individuals showing active symptoms of herpesvirus infections.
• Immunocompromised individuals should avoid exposure to high-risk environments (e.g., childcare centers).
• Pregnant individuals should avoid contact with known cytomegalovirus infections to prevent congenital transmission.
• Vaccination is not available for most other human herpesviruses, though CMV vaccines are under investigation.

When to Seek Professional Help

Seek medical attention if you experience persistent fever, unexplained rash, organ-specific symptoms (e.g., shortness of breath, jaundice), or signs of neurologic involvement (e.g., confusion, seizures). Immunocompromised individuals or those with weakened immune systems should contact a healthcare provider promptly for any concerning symptoms, as early intervention may prevent severe disease.

Tips for Medical Coders

When coding for other human herpesviruses (ICD-10-CM code B10), ensure documentation specifies the causative virus (e.g., cytomegalovirus, HHV-6) and any associated complications (e.g., pneumonitis, encephalitis) to support accurate code assignment. Verify that the code aligns with the clinical scenario and avoid using B10 for infections caused by HSV, VZV, or EBV, which have distinct codes. Document the patient’s immune status and organ involvement to justify code specificity.